Medical Cannabis Companies Move to Defend Rescheduling as Legal Challenges Intensify
Two medical cannabis companies have filed a motion to intervene in active lawsuits aimed at blocking the Trump administration's effort to move marijuana from Schedule I to Schedule III under the


